Catalyst Funds Management Pty Ltd Invests $961,000 in Danaher Corporation $DHR

Catalyst Funds Management Pty Ltd bought a new position in Danaher Corporation (NYSE:DHR) during the 4th quarter, HoldingsChannel reports. The fund bought 4,200 shares of the conglomerate’s stock, valued at approximately $961,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in DHR. JPL Wealth Management LLC bought a new position in shares of Danaher in the third quarter worth approximately $25,000. Elevated Capital Advisors LLC bought a new position in shares of Danaher in the fourth quarter worth approximately $26,000. WFA of San Diego LLC bought a new position in shares of Danaher in the second quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd bought a new position in shares of Danaher in the third quarter worth approximately $27,000. Finally, Financial Life Planners bought a new position in Danaher during the third quarter valued at approximately $32,000. Institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on DHR. Evercore increased their price objective on shares of Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research report on Tuesday, April 21st. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. Robert W. Baird lowered their price objective on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a research report on Friday, April 17th. Barclays lowered their price objective on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Finally, Morgan Stanley lowered their price objective on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Nineteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $238.65.

Danaher Stock Down 0.7%

Shares of Danaher stock opened at $172.12 on Friday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a market cap of $121.82 billion, a price-to-earnings ratio of 33.29, a price-to-earnings-growth ratio of 2.30 and a beta of 0.81. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The company’s 50 day moving average is $183.52 and its 200 day moving average is $208.73.

Danaher (NYSE:DHR) last announced its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period in the prior year, the company earned $1.88 earnings per share. The firm’s revenue was up 3.7% on a year-over-year basis. Research analysts anticipate that Danaher Corporation will post 8.43 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.